Sincalide Patent Expiration

1. Kinevac patent expiration

KINEVAC IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6803046 BRACCO Sincalide formulations
Aug, 2022

(1 year, 10 months ago)




Market Authorisation Date: 01 January, 1982

Treatment: NA

Dosage: INJECTABLE

More Information on Dosage

KINEVAC family patents

Family Patents

2. Sincalide patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11318100 MAIA PHARMS INC Storage stable sincalide formulations
Apr, 2038

(13 years from now)

US11110063 MAIA PHARMS INC Storage stable sincalide formulations
Apr, 2038

(13 years from now)

US11737983 MAIA PHARMS INC Storage stable sincalide formulations
Apr, 2038

(13 years from now)




Market Authorisation Date: 22 November, 2022

Treatment: Stimulate gallbladder contraction. as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis; Diagnostic imaging by ac...

Dosage: POWDER

More Information on Dosage

SINCALIDE family patents

Family Patents